ArticleLiver international : official journal of the International Association for the Study of the Liver2026
Correction to 'Focus on Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis'.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.